(Q33493954)

27 July 2017

title

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome (English)

1 reference

antiphospholipid syndrome

27 July 2017

1 reference

1 reference

4

Shoenfeld Y

1 reference

27 July 2017

2

Blank M

1 reference

27 July 2017

1

Krause I

1 reference

27 July 2017

Gilbrut B

3

1 reference

27 July 2017

publication date

1 April 1993

1 reference

American Journal of Reproductive Immunology

27 July 2017

published in

1 reference

27 July 2017

volume

29

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

155-161

1 reference

Antiphospholipid antibody syndrome: immunologic and clinical aspects

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Fetal loss treatment in patients with antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Recurrent adverse pregnancy outcome and antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

The paradoxical thrombogenic effect of aspirin in experimental thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

THROMBOTIC TENDENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1993.TB00581.X

10.1111/J.1600-0897.1993.TB00581.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference